• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings

cafead

Administrator
Staff member
  • cafead   Mar 13, 2024 at 10:42: PM
via It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor. After paying Duato $13.1 million in his first year as CEO, the pharma giant more than doubled his compensation to $28.4 million last year, according to a regulatory filing.

article source
 

<